SCHEMBL29434720

SCHEMBL29434720

O=c1ccc2nc[nH]c(=O)c2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
PARP1 P09874 13/20 0.46
PDPK1 O15530 2/20 0.46
CA12 O43570 1/20 0.46
ALOX15 P16050 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CA9 Q16790 1/20 0.46
TNKS2 Q9H2K2 1/20 0.46
CHEK1 O14757 2/20 0.44
PIM1 P11309 2/20 0.44
AKT1 P31749 1/20 0.44
FLT3 P36888 1/20 0.44
PIM3 Q86V86 1/20 0.44
KDM4A O75164 1/20 0.42
KDM4B O94953 1/20 0.42
KDM5C P41229 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
KDM5B Q9UGL1 1/20 0.42
KDM3A Q9Y4C1 1/20 0.42
IP6K1 Q92551 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1415174 0.75 ALDH1A1 (0.52) ALDH1A1PARP1PDPK1CA12ALOX15
SCHEMBL2272870 0.75 PARP1 (0.39) ALDH1A1PARP1PDPK1CA12ALOX15
SCHEMBL906665 0.71 ALDH1A1 (0.52) ALDH1A1PARP1PDPK1CA12ALOX15
SCHEMBL8237226 0.71 PARP1 (0.47) ALDH1A1PARP1PDPK1CA12ALOX15
SCHEMBL1374558 0.70 PRKCI (0.44) ALDH1A1PARP1PDPK1CA12ALOX15
SCHEMBL25194691 0.68 SMN1; SMN2 (0.48) ALDH1A1PARP1PDPK1CA12ALOX15
Hypoxanthine SCHEMBL17457034 0.67 ALDH1A1 (0.62) ALDH1A1PDPK1SLC2A1
SCHEMBL14494444 0.67 PDE3B (0.44)
Hypoxanthine SCHEMBL7037918 0.66 ALDH1A1 (1.00) ALDH1A1PDPK1SMN1; SMN2CHEK1RPS6KA3
Hypoxanthine SCHEMBL25381 0.66 ALDH1A1 (1.00) ALDH1A1PDPK1SMN1; SMN2CHEK1RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110225911-B Oxadiazolone transient receptor potential channel inhibitors 豪夫迈·罗氏有限公司 2022-04-05 CN disclosed